Wegozy comes in a slightly higher dosage but continues with the once-weekly injections
References The clinical literature cited below establishes the physiological evidence regarding lean mass degradation, bone density reduction, and nutrient deficiencies associated with GLP-1 therapies
Conversely, diverse microbiomes rich in fiber-fermenting bacteria produce short-chain fatty acids (SCFAs) such as butyrate and propionate
Human studies need to be more robust to be able to comment on the safety of the long-term use of these peptides
Compounded GLP-1s (from compounding pharmacies, dispensed in vials) you may need insulin syringes or pen needles depending on the device you were given
Sarah Shultz, a biomechanist and the dean of the School of Health Sciences at the University of New Haven, surmised to ESPN that GLP-1 drugs could have substantial benefits for athletes like Williams, noting that "when you have both weight loss and a change in inflammation, which is what the hormone's going to do for you, then you're going to lose that joint pain" and "when you think about it in terms of blood sugar, if her blood sugar is being regulated in a way that it wasn't previously, which is what the drug is supposed to do, now fatigue isn't as big of a deal either, and recovery is easier." Only time will tell if GLP-1 meds eventually become classified as a banned performance-enhancing drug